Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

6.86
Delayed Data
As of May 27
 -0.21 / -2.97%
Today’s Change
2.57
Today|||52-Week Range
10.00
+54.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues760.0K0.000.000.00
 
 
Depreciation And Amortization88.0K88.0K93.0K93.0K
 
 
 
 
 
 
Operating ExpensesGross Income---88.0K-93.0K-93.0K
 
 
 
 
General Expenses1.8M1.7M2.2M1.7M
 
 
 
 
 
Research And Development1.1M1.0M1.1M700.0K
 
 
 
 
 
Total Operating Expenses1.9M1.8M2.3M1.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.1M-1.8M-2.3M-1.8M
 
 
 
 
 
Extraordinary Credit0.000.000.004.0K
 
 
Extraordinary Charge-1.2M-2.0K--0.00
 
 
 
Other Expenses-4.0K-3.0K-44.0K-19.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.3M-1.8M-2.3M-1.8M
 
 
 
 
 
Net Income-2.3M-1.8M-2.3M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.1M20.1M20.1M20.1M
 
 
 
 
 
Shares To Calculate EPS Diluted20.1M20.1M20.1M20.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.09-$0.11-$0.09
 
 
 
 
 
EPS Diluted-$0.11-$0.09-$0.11-$0.09